D

Doxa AB
STO:DOXA

Watchlist Manager
Doxa AB
STO:DOXA
Watchlist
Price: 1.018 SEK 0.79% Market Closed
Market Cap: 1.3B SEK
Have any thoughts about
Doxa AB?
Write Note

Doxa AB
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Doxa AB
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
D
Doxa AB
STO:DOXA
Revenue
kr16.8m
CAGR 3-Years
11%
CAGR 5-Years
-11%
CAGR 10-Years
9%
O
OssDsign AB
STO:OSSD
Revenue
kr112.2m
CAGR 3-Years
65%
CAGR 5-Years
53%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Revenue
kr750.6m
CAGR 3-Years
48%
CAGR 5-Years
28%
CAGR 10-Years
25%
Bactiguard Holding AB
STO:BACTI B
Revenue
kr223.2m
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Revenue
€352.4m
CAGR 3-Years
32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
S2Medical AB (publ)
STO:S2M
Revenue
kr10.6m
CAGR 3-Years
-3%
CAGR 5-Years
45%
CAGR 10-Years
N/A
No Stocks Found

Doxa AB
Glance View

Market Cap
1.3B SEK
Industry
Health Care

Doxa AB engages in the development, manufacture, and commercialization of bioceramic dental products. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2014-04-07. The firm develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.

DOXA Intrinsic Value
0.75 SEK
Overvaluation 26%
Intrinsic Value
Price
D

See Also

What is Doxa AB's Revenue?
Revenue
16.8m SEK

Based on the financial report for Jun 30, 2024, Doxa AB's Revenue amounts to 16.8m SEK.

What is Doxa AB's Revenue growth rate?
Revenue CAGR 10Y
9%

Over the last year, the Revenue growth was 211%. The average annual Revenue growth rates for Doxa AB have been 11% over the past three years , -11% over the past five years , and 9% over the past ten years .

Back to Top